Integrating mechanisms of response and resistance against the tubulin binding agent Eribulin in preclinical models of osteosarcoma
- Type
- Retraction
- Notice date
- 10/11/2024 0:00
- Journal
- Oncotarget
- Publisher
- Impact Journals
- Notice DOI
- 10.18632/oncotarget.28663
- Original paper DOI
- 10.18632/oncotarget.13358